NEW YORK , June 23, 2023 /PRNewswire/ --  Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides an update to shareholders. Due to the capital constraints and costs associated with the audit pro
Full Story >>
Vote
+46